Use of Physical Therapy for Low Back Pain by Medicaid Enrollees

Physical Therapy
Julie M FritzJosette Dorius

Abstract

Medicaid insures an increasing proportion of adults in the United States. Physical therapy use for low back pain (LBP) in this population has not been described. The study objectives were: (1) to examine physical therapy use by Medicaid enrollees with new LBP consultations and (2) to evaluate associations with future health care use and LBP-related costs. The study was designed as a retrospective evaluation of claims data. A total of 2,289 patients with new LBP consultations were identified during 2012 (mean age=39.3 years [SD=11.9]; 68.2% women). The settings in which the patients entered care and comorbid conditions were identified. Data obtained at 1 year after entry were examined, and physical therapy use was categorized with regard to entry setting, early use (within 14 days of entry), or delayed use (>14 days after entry). The 1-year follow-up period was evaluated for use outcomes (imaging, injection, surgery, and emergency department visit) and LBP-related costs. Variables associated with physical therapy use and cost outcomes were evaluated with multivariate models. Physical therapy was used by 457 patients (20.0%); 75 (3.3%) entered care in physical therapy, 89 (3.9%) received early physical therapy, and 298 (13.0%) re...Continue Reading

References

Nov 19, 2003·American Journal of Health Promotion : AJHP·Shirley MusichDee W Edington
Feb 6, 2004·Administration and Policy in Mental Health·Pamela K Adelmann
Sep 15, 2010·Archives of Internal Medicine·Jennifer Brennan BradenMark D Sullivan
Nov 26, 2010·Spine·Alfred Campbell GellhornJanna Friedly
Apr 1, 2011·Physical Therapy·Michael K Nicholas, Steven Z George
May 24, 2011·The Spine Journal : Official Journal of the North American Spine Society·Jasmina I IvanovaRalph W Swindle
Jul 27, 2012·The New England Journal of Medicine·Benjamin D SommersArnold M Epstein
Jan 8, 2013·The Quarterly Journal of Economics·Amy FinkelsteinUNKNOWN Oregon Health Study Group
Jul 31, 2013·JAMA Internal Medicine·John N MafiBruce E Landon
Dec 25, 2013·Annals of Internal Medicine·Ryan A Crowley, William Golden
Feb 28, 2014·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Lisa Clemans-CopeDean Resnick
Mar 29, 2014·The New England Journal of Medicine·Brendan SalonerBenjamin D Sommers
Jan 1, 2013·Medicare & Medicaid Research Review·David K Baugh, Shinu Verghese
Jan 1, 2013·Medicare & Medicaid Research Review·Benjamin D SommersArnold M Epstein
Oct 14, 2014·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Paul PukurdpolAdit A Ginde
Nov 15, 2014·BMC Health Services Research·Mary E CharlsonWalid Michelen
Dec 17, 2014·Nursing Research·Jessica CastnerSharon Hewner
Dec 18, 2014·The New England Journal of Medicine·Sara Rosenbaum

❮ Previous
Next ❯

Citations

Mar 5, 2017·The Journal of Orthopaedic and Sports Physical Therapy·Carlos E LadeiraRubens A da Silva
Dec 3, 2015·Physical Therapy·Linda Resnik, Janet K Freburger
Jan 5, 2018·Medical Care Research and Review : MCRR·Jean M Mitchell, Jack Hadley
Jul 16, 2021·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Mary GrayEsther K Choo
Jul 21, 2021·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·John Jake MagelAdam J Gordon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.